Argitalpenak (56) JOSÉ EUGENIO GUERRERO SANZ argitalpenak

2018

  1. Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit

    Journal of Critical Care, Vol. 48, pp. 172-177

  2. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

2016

  1. Clinical factors associated with inappropriate prophylaxis of venous thromboembolic disease in critically ill patients. A single day cross-sectional study

    Thrombosis Research, Vol. 143, pp. 111-117

  2. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  3. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis

    Journal of Infection, Vol. 72, Núm. 2, pp. 143-151

2014

  1. PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain

    Intensive Care Medicine, Vol. 40, Núm. 11, pp. 1698-1708

  2. Papel de la procalcitonina plasmática en el diagnóstico de la neumonía asociada a ventilación mecánica: Revisión sistemática y metaanálisis

    Medicina Intensiva, Vol. 38, Núm. 6, pp. 337-346

  3. Profilaxis de la enfermedad tromboembólica venosa en el paciente crítico: Aproximación a la práctica clínica en la Comunidad de Madrid

    Medicina Intensiva, Vol. 38, Núm. 6, pp. 347-355

2012

  1. Corticosteroid therapy in patients with primary viralpneumonia due to pandemic (H1N1) 2009influenza

    Journal of Infection, Vol. 64, Núm. 3, pp. 311-318

  2. Uso de oxigenador de membrana extracorpóreo en pacientes con insuficiencia respiratoria aguda grave refractaria en la epidemia de gripe estacional 2010-2011 por influenza A (H1N1) en España

    Medicina Intensiva, Vol. 36, Núm. 3, pp. 193-199

2011

  1. Bradicardia sinusal sintomática tras inicio de octreotide subcutánea

    Medicina Intensiva

  2. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus

    Chest, Vol. 139, Núm. 3, pp. 555-562

  3. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386

  4. Pandemic and post-pandemic Influenza A (H1N1) infection in critically ill patients

    Critical Care, Vol. 15, Núm. 6

  5. Primera epidemia de gripe estacional después de la pandemia por gripe A en 2009: Descripción de los primeros 300 ingresos en UCI españolas

    Medicina Intensiva, Vol. 35, Núm. 4, pp. 208-216

  6. Severe 2009 A/H1N1v influenza in pregnant women in Spain

    Critical Care Medicine

  7. Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain

    Respirology, Vol. 16, Núm. 1, pp. 78-85

2010

  1. Pandemic Influenza A in the ICU: Experience in Spain and Latin America GETGAG/SEMICYUC/(Spanish Work Group on Severe Pandemic Influenza A/SEMICYUC)

    Medicina Intensiva, Vol. 34, Núm. 2, pp. 87-94

2009

  1. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

    Critical Care, Vol. 13, Núm. 5

  2. Prescription of antibiotics in intensive care units in Latin America: An observational study

    Journal of Chemotherapy, Vol. 21, Núm. 5, pp. 527-534